Literature DB >> 20607507

[Tumors and tumor-like lesions of the orbit].

W E Lieb1.   

Abstract

This article gives an overview of the most common and clinically relevant tumors of the orbit and their treatment. The most common orbital tumors in childhood are cystic tumors, such as dermoid and epidermoid cysts. Capillary hemangiomas are the most common primary benign tumors of the orbit and appear mostly in the first year of life. In contrast teratomas are rare and histologically mostly benign. Neural tumors are, for example, gliomas of the optic nerve and in 25-50% of cases are associated with neurofibromatosis. Rhabdomyosarcoma is a rapidly growing malignant orbital tumor whereby the stage and localization are the most important prognostic factors for survival chance in children. Leukemia can be associated with a chloroma especially in the first decade of life. Lymphoproliferative diseases, vascular and cystic tumors in particular are known as tumors of adulthood. In addition to fibroosseous and mesenchymal tumors, neural forms, such as schwannomas are also important. Secondary tumors of the orbit are often manifested in the nose and paranasal sinuses.

Entities:  

Mesh:

Year:  2010        PMID: 20607507     DOI: 10.1007/s00106-010-2140-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  49 in total

1.  Adenoid cystic carcinoma of the lacrimal gland: is there a cure...yet?

Authors:  George B Bartley; Gerald J Harris
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2002-09       Impact factor: 1.746

2.  Perineural spread of malignancy.

Authors:  R G Weatherhead
Journal:  Aust N Z J Ophthalmol       Date:  1991-02

3.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

4.  Surgical exploration of the orbit.

Authors:  J E Wright
Journal:  Trans Ophthalmol Soc U K       Date:  1979-07

Review 5.  Tumors metastatic to the orbit: a changing picture.

Authors:  R A Goldberg; J Rootman; R A Cline
Journal:  Surv Ophthalmol       Date:  1990 Jul-Aug       Impact factor: 6.048

Review 6.  Ocular adnexal lymphoid tumors.

Authors:  S A Lauer
Journal:  Curr Opin Ophthalmol       Date:  2000-10       Impact factor: 3.761

Review 7.  Rhabdomyosarcoma: review for the ophthalmologist.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

8.  Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.

Authors:  A Fiorillo; R Migliorati; M Grimaldi; P Vassallo; G Canale; F Tranfa; G Uccello; M Fiore; P Muto; G Menna
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

Review 9.  Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Authors:  Sureka Thiagalingam; Maree Flaherty; Frank Billson; Kathryn North
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

10.  Surgical Principles for Children/Adolescents With Newly Diagnosed Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  David A Rodeberg; Charles N Paidas; Thom L Lobe; Kenneth Brown; Richard J Andrassy; William M Crist; Eugene S Wiener
Journal:  Sarcoma       Date:  2002
View more
  4 in total

Review 1.  [Possible surgical approaches to the orbit].

Authors:  H-J Welkoborsky; S K Plontke
Journal:  HNO       Date:  2018-11       Impact factor: 1.284

Review 2.  [Epithelioid sarcoma of the orbit].

Authors:  M Thranitz; T Berg; C Kneifel; K Stock; S Knipping
Journal:  HNO       Date:  2014-03       Impact factor: 1.284

Review 3.  [Clinical and neuroradiological diagnostics of orbital tumors].

Authors:  C M Poloschek; W A Lagrèze; G J Ridder; C Hader
Journal:  Ophthalmologe       Date:  2011-06       Impact factor: 1.059

4.  [The simultaneous appearance of three uncommon tumours].

Authors:  J Brandstätter; S Gall; A Chavan; L Ermert; D Scriba; F Hoppe
Journal:  HNO       Date:  2014-03       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.